Salarius Pharmaceuticals, INC. 8-K Filing
Ticker: DCOY · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1615219
Sentiment: neutral
Filing Stats: 642 words · 3 min read · ~2 pages · Grade level 12.6 · Accepted 2025-11-17 17:23:58
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 SLRX The Nasdaq Capital Market Indi
Filing Documents
- flks-20251117.htm (8-K) — 27KB
- 0001615219-25-000166.txt ( ) — 141KB
- flks-20251117.xsd (EX-101.SCH) — 2KB
- flks-20251117_lab.xml (EX-101.LAB) — 22KB
- flks-20251117_pre.xml (EX-101.PRE) — 13KB
- flks-20251117_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SALARIUS PHARMACEUTICALS, INC. Date: November 17, 2025 By: /s/ Mark J. Rosenblum Mark J. Rosenblum Executive Vice President & Chief Financial Officer